This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
Opinion/decision on a Paediatric investigation plan (PIP): Agamree, Vamorolone, ...
A House budget bill does not mention Medicaid by name, but directs the committee...
Hedge fund’s short position is the biggest in the FTSE 100 group in more than a ...
Opinion/decision on a Paediatric investigation plan (PIP): Olumiant, Baricitinib...
Opinion/decision on a Paediatric investigation plan (PIP): Mounjaro, Tirzepatide...
Nearly 1,300 probationary employees at the CDC are being forced out under the Tr...
In 2024’s fourth quarter, Moderna’s cost of sales came out to $739 million, whic...
Bambusa Therapeutics has raised about $90 million to build out a pipeline of nex...
Human medicines European public assessment report (EPAR): Paxlovid, nirmatrelvir...
Opinion/decision on a Paediatric investigation plan (PIP): Enerzair Breezhaler, ...
Human medicines European public assessment report (EPAR): Zinforo, ceftaroline f...
Human medicines European public assessment report (EPAR): Karvea, irbesartan, Da...
Two months after Allogene abandoned plans for its CAR-T in leukemia, analysts ha...